This inventor holds 4 USPTO granted patents. Top assignees: Children's Hospital, University of Iowa Research Foundation. Active years: 1992-1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 1992-1993
Title: The Innovative Contributions of Richard C. Gehrz
Introduction
Richard C. Gehrz, an accomplished inventor based in Mendota Heights, Minnesota, has made significant strides in the field of immunology. With a total of four patents to his name, Gehrz's work focuses on the isolation and purification of glycoproteins related to human cytomegalovirus, offering valuable advancements in diagnosis and therapy.
Latest Patents
Gehrz's latest patents showcase his dedication to medical innovation. One such patent involves the development of immunogenic glycoproteins of human cytomegalovirus, where glycopeptides have been isolated and purified. These discoveries are pivotal for creating antibodies that are reactive and beneficial for diagnosing and treating infections caused by this virus. Another notable patent from Gehrz concerns substantially pure immunogenic glycoprotein complexes of the gCII family, which can be derived from the membrane envelope of human cytomegalovirus. These constituent glycoproteins enhance the toolbox for therapeutic applications and diagnostics.
Career Highlights
Gehrz has had a remarkable career, contributing his expertise to prominent institutions. He has worked closely with Children's Hospital and the University of Iowa Research Foundation, advancing research initiatives that focus on understanding and combating viral infections.
Collaborations
Throughout his career, Gehrz has collaborated with esteemed colleagues, including Bruce E. Kari and Nancy O. Lussenhop. These partnerships have facilitated significant advancements in the field and demonstrate the importance of teamwork in scientific discovery.
Conclusion
Richard C. Gehrz's innovative spirit and dedication to scientific research have led to advancements in the understanding of human cytomegalovirus. His patents not only reflect his ingenuity as an inventor but also hold promising implications for medical diagnostics and therapies. As the field of immunology continues to evolve, Gehrz remains a key player in this vital area of research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile